Bizarre Patents
Pillow with retractable umbrella
A pillow assembly having a supporting assembly and a retractable umbrella assembly that is easily transportable and allows a user to support his/her head while covering their face from sunlight.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6903052 | Nematicidal compositions and methods The invention concerns the use of certain compounds related to fatty acids to control nematodes that infest plants or the situs of plants. Nematodes that parasitize animals can also be controlled using the methods and composition of this invention. Certain of the us... | 06/07/2005 |
| 6903070 | Glycopeptide carboxy-saccharide derivatives Disclosed are glycopeptide derivatives substituted at the C-terminus and/or the R-terminus with a substituent that comprises one or more saccharide groups and a carboxy group; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed gl... | 06/07/2005 |
| 6900176 | Pest control agents/depsipeptides The present invention relates to the use of 24-membered cyclodepsipeptides of the formula (1) in which R1 and R2 are as defined in the description, for controlling animal pests in veteri... | 05/31/2005 |
| 6894026 | Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders Methods and compositions are provided for prophylaxis and treatment of breast cancer involving administration of a therapeutically effective amount of carbetocin and/or other long-acting oxytocin analogues. 1-Butanoic acid-2-(O-methyl-L-tyrosine)-1-carbaoxytocin (ca... | 05/17/2005 |
| 6890902 | Cytotoxic modified lactoferrin peptides The present invention provides a modified lactoferrin peptide which is cytotoxic, 7 to 25 amino acids in length, with three or more cationic residues and which has one or more extra bulky and lipophilic amino acids as compared to the native lactoferrin sequence, as ... | 05/10/2005 |
| 6890901 | Hyaluronic drug delivery system Pharmaceutical compositions comprising a mixture of hyaluronic acid and liposomes. Preferably, the pharmaceutical compositions further include a pharmaceutically active substance such as cyclosporin A encapsulated in the liposomes. A method for preparing a pharmaceu... | 05/10/2005 |
| 6884774 | Cyclic hexapeptide derivatives This invention relates to new polypeptide compound represented by the general formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined in the description or a salt thereof which has antimicrobial ... | 04/26/2005 |
| 6884868 | Cyclic hexapeptides having antibiotic activity This invention relates to new polypeptide compound represented by general formula (I), wherein R1, R2, R3, R4, R5 and R6 are as defined in the description or a salt thereof which has antimicrobial act... | 04/26/2005 |
| 6881719 | β-turn peptidomimetic cyclic compounds Proteolytically stable small molecule β-turn peptidomimetic compounds have been identified as agonists or antagonists of neurotrophin receptors, such as TrkA. A compound of particular interest binds the immunoglobulin-like C2 region of the extracellular domain of T... | 04/19/2005 |
| 6875740 | Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens There is described antifungal combination use of known antifungal agents such as the azoles or polyenes in combination with a lipopeptide compound antifungal agent. More particularly, the invention relates to antifungal combination use of azols such as fluconazole v... | 04/05/2005 |
| 6872702 | Inhibitors for urokinase receptor The present invention concerns peptides as inhibitors of the binding of urokinase to the urokinase receptor. These peptides, which are preferably cyclic, are suitable as pharmaceutical agents for diseases that are mediated by urokinase and its receptor. ... | 03/29/2005 |
| 6872803 | Peptides The present invention provides peptides represented by the following formula (A): wherein Q represents a physiologically active peptide moiety; X each represents the same or different α-amino acid residue; M represent... | 03/29/2005 |
| 6864233 | Fungicidal echinocandin derivatives and their preparation The invention concerns compounds of general formula (I) wherein: R1 represents a hydrogen atom, a hydroxy radical, Ob or Ncd; A represents an oxygen atom, a CH2 radical or a NH radical; B represents the radical of a steroid; R3 repre... | 03/08/2005 |
| 6864234 | Somatostatin agonists The present invention is directed to cyclic peptides of formula (I): X-A1-cyclo(D-Cys-A3-A4-Lys-A6-A7)-A8-Y, or a pharmaceutically acceptable salt thereof. The peptides bind selectively to the somatos... | 03/08/2005 |
| 6858585 | Cyclic depsipeptides and drugs containing the same as the active ingredient Cyclic depsipeptides represented by the formula wherein: R is a straight or branched alkyl group of 5-20 carbon atoms or a straight or branched alkoxymethyl group of 5-15-carbon atoms; A, B, D, E and F independ... | 02/22/2005 |
| 6855692 | Histogranin peptides and their analgesic use The invention relates to linear and cyclic peptide and pseudopeptide compounds useful as analgesics, pharmaceutical compositions comprising such compounds, the use of the compounds and the compositions in the treatment of pain, and commercial packages containing suc... | 02/15/2005 |
| 6852689 | Methods for administration of antibiotics The invention provides methods for administering a therapeutically effective amount of daptomycin while minimizing skeletal muscle toxicity. The methods provide daptomycin administration at a dosing interval of 24 hours or greater. This long dosing interval minimize... | 02/08/2005 |
| 6852688 | Compositions for treating diabetic retinopathy and methods of using same The subject invention provides novel methods and materials for treating diabetic retinopathy. One embodiment of the subject invention involves the co-administration of a somatostatin, or analogue thereof, and a thryoid-related substance such as thyroxine. Somatostat... | 02/08/2005 |
| 6849709 | Aerothricin derivatives The present invention relates to novel Aerothricins represented by the Formula (I), and pharmaceutically acceptable salts thereof. The present invention also relates to a pharmaceutical composition comprising a... | 02/01/2005 |
| 6841530 | Semi-synthetic studies toward didemnin analogues Disclosed are semi-synthetic methods for the preparation of Didemnin Analogs. The compounds of this type are illustrated in Formula (I). ... | 01/11/2005 |
| 6841533 | Conformationally constrained backbone cyclized interleukin-6 antagonists Novel peptides which are conformationally constrained backbone cyclized antagonists of IL-6, are disclosed. Methods for synthesizing the IL-6 antagonists are also disclosed. Furthermore, pharmaceutical compositions comprising IL-6 antagonists, and methods of using s... | 01/11/2005 |
| 6838441 | Albumin for treating meconium aspiration syndrome The present invention provides a method of treating meconium aspiration syndrome, said method comprising administering to a subject in need of treatment a therapeutically effective amount of albumin. A further aspect of the invention relates to the use of albumin in... | 01/04/2005 |
| 6833353 | Use of immunosuppressants for MMP mediated diseases A new use of immunosuppressant for treating or preventing MMp-medicated diseases is provided. The preferred immunosuppresants are tacrolimus, cyclosporing A or 33-epi-chloro-33-desoxyascomycin (pimecrolimus). Particularly, preferable MMP-mediated diseases are the di... | 12/21/2004 |
| 6828301 | Pharmaceutical compositions for hepatitis C viral protease inhibitors Disclosed are pharmaceutical compositions of hepatitis C viral protease inhibitors having improved bioavailability, and methods of using these compositions for inhibiting the replication of the hepatitis C virus (HCV) and for the treatment of an HCV infection. These... | 12/07/2004 |
| 6828300 | Pest control agent/PF 1022-221 The present invention relates to the use of a 24-membered cyclodepsipeptide of the formula (I) for controlling animal pests in agriculture, forests and the protection of materials, and to pesticides comprising this dep... | 12/07/2004 |
| 6828299 | Polyhydroxy glycopeptide derivatives Disclosed are polyhydroxy derivatives of glycopeptides and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents. ... | 12/07/2004 |
| 6825317 | Cyclic tetrapeptide derivatives and pharmaceutical uses thereof The present invention provides a cyclic tetrapeptide derivative represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: wherein each of R2... | 11/30/2004 |
| 6818619 | Chimeric natriuretic peptides Peptides of Dendroaspis, including chimeric peptides thereof, are provided, as well as methods of using the peptides as natriuretics, diuretics, and/or vasodilators. ... | 11/16/2004 |
| 6818615 | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents A method of increasing the bioavailability upon oral administration of a pharmacologically active target agent, particularly an antitumor or antineoplastic agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), com... | 11/16/2004 |
| 6815437 | Streptogramines, their preparation and compositions containing them Group A streptogramin derivatives of formula (I): the salts thereof, and mixtures of stereoisomers thereof, as well as processes for preparing them and pharmaceutical compositions comprising them are disclosed. ... | 11/09/2004 |
| 6809177 | Process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues The invention relates to a process for the conversion of echinocandin class of peptides to their C4-homotyrosine monodeoxy analogues, particularly mulundocandin to deoxymulundocandin, which consists of a single step selective reduction of C4-htyr (homotyrosine) hydr... | 10/26/2004 |
| 6809077 | Cyclosporin analogs for the treatment of autoimmune diseases The present invention relates to a cyclosporin analog of the following formula (I) or a pro-drug or pharmaceutically acceptable salt thereof: In particular, residue A maybe represented by either formula A1 or A2 as ill... | 10/26/2004 |
| 6797694 | Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction The present invention relates to chemical compounds having inhibitory activity on an intermediate conductance Ca2+ activated potassium channel (IKCa), and the use of such compounds for the treatment or alleviation of diseases or conditions rela... | 09/28/2004 |
| 6794364 | Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides A copolymer comprising an N-acylated derivative, and a composition comprising said copolymer and a polypeptide, said polypeptide comprising at least one effective ionogenic amine, wherein at least 50 percent, by weight, of said polypeptide present in said compositio... | 09/21/2004 |
| 6794489 | Compositions and methods for treatment of sexual dysfunction Compositions and methods are provided for treatment of sexual dysfunction in mammals, including male sexual dysfunction, such as erectile dysfunction, and female sexual dysfunction. In one embodiment, a peptide-based composition including the peptide sequence Ac-Nle... | 09/21/2004 |
| 6794490 | Lipopeptides as antibacterial agents The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel... | 09/21/2004 |
| 6794362 | Asparagine containing elastin peptide analogs The present invention is directed to a composition which is used to enhance the elasticity and/or appearance of tissue. Specifically, the present invention is directed to a composition formulated from peptides or peptide-like compounds having low molecular weights a... | 09/21/2004 |
| 6793925 | Pseudomycin natural products The invention relates to pseudomycin natural products including pseudomycins A′ and B′, methods for making such pseudomycins, and methods employing antifungal activity of these pseudomycins. NMR and mass spectrometry indicate formula (I) for pseudomycin A′. NM... | 09/21/2004 |
| 6790830 | Use of 3-position cyclosporin derivatives for hair growth The present invention discloses a hair growth promoting agent comprising a cyclosporin derivative as an active ingredient, and more particularly, a hair growth promoting agent comprising a cyclosporin A derivative substituted in the 3-position as an active ingredien... | 09/14/2004 |
| 6790833 | Antifungal and antibacterial agents The present invention discloses peptides obtained from the MUCD1 domain of the saliva mucin glycoprotein MUC7. The peptides are between 8 and 20 amino acids in length and have a net positive charge. The peptides are obtained from the C-terminus of the MUC7D1 protein... | 09/14/2004 |
